A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer

Sean Dineen, Patrick M. Lynch, Miguel A. Rodriguez-Bigas, Sarah Bannon, Melissa Taggart, Colleen Reeves, Cathy Modaro, Michael Overman, George J. Chang, John M. Skibber, Y. Nancy You

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Improving the quality of health care is a national priority, and providing patient-centered care is one of the 6 key areas for quality improvement. In the setting of patients with young-onset colorectal cancer (CRC), appropriate genetic workup and testing for potential underlying inherited CRC syndromes is fundamental to patient-centered care. Lynch syndrome (LS) is the most common of these inherited syndromes, and current recommendations from the NCCN and other professional societies advocate universal screening for LS among young patients with CRC. However, practical implementation of these guidelines often falls short. Methods: We conducted a prospective quality improvement intervention trial to optimize universal screening for LS in young (age<50 years) patients, involving 356 eligible patients during the 12-month preintervention period and 299 patients during the postintervention. Results: Applying the Six Sigma conceptual framework, we demonstrated a significant increase in use of tumor-based molecular testing and subsequent confirmatory germline mutation testing for LS. This led to identification of more patients to be managed as having LS and of more first- and second-degree relatives to benefit from the testing results. Conclusions: This study demonstrated the successful application of a quality improvement conceptual framework for the universal adoption of molecular biomarker testing in patients with cancer, and for improving adherence to NCCN Clinical Practice Guidelines in Oncology for CRC Screening. As molecular and genetic testing is becoming increasingly common, we present a prototype study for improving the adoption of molecular studies and the provision of guideline-based patient-centered care. (J Natl Compr Canc Netw 2015;13:865-872).

Original languageEnglish (US)
Pages (from-to)865-872
Number of pages8
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number7
StatePublished - Jul 1 2015

Fingerprint

Total Quality Management
Genetic Testing
Quality Improvement
Hereditary Nonpolyposis Colorectal Neoplasms
Colorectal Neoplasms
Patient-Centered Care
Guidelines
Germ-Line Mutation
Quality of Health Care
Early Detection of Cancer
Practice Guidelines
Molecular Biology
Neoplasms
Biomarkers

ASJC Scopus subject areas

  • Oncology

Cite this

A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer. / Dineen, Sean; Lynch, Patrick M.; Rodriguez-Bigas, Miguel A.; Bannon, Sarah; Taggart, Melissa; Reeves, Colleen; Modaro, Cathy; Overman, Michael; Chang, George J.; Skibber, John M.; Nancy You, Y.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, No. 7, 01.07.2015, p. 865-872.

Research output: Contribution to journalArticle

Dineen, S, Lynch, PM, Rodriguez-Bigas, MA, Bannon, S, Taggart, M, Reeves, C, Modaro, C, Overman, M, Chang, GJ, Skibber, JM & Nancy You, Y 2015, 'A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 7, pp. 865-872.
Dineen, Sean ; Lynch, Patrick M. ; Rodriguez-Bigas, Miguel A. ; Bannon, Sarah ; Taggart, Melissa ; Reeves, Colleen ; Modaro, Cathy ; Overman, Michael ; Chang, George J. ; Skibber, John M. ; Nancy You, Y. / A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer. In: JNCCN Journal of the National Comprehensive Cancer Network. 2015 ; Vol. 13, No. 7. pp. 865-872.
@article{5c0c9c58526b4097891ffab007082041,
title = "A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer",
abstract = "Background: Improving the quality of health care is a national priority, and providing patient-centered care is one of the 6 key areas for quality improvement. In the setting of patients with young-onset colorectal cancer (CRC), appropriate genetic workup and testing for potential underlying inherited CRC syndromes is fundamental to patient-centered care. Lynch syndrome (LS) is the most common of these inherited syndromes, and current recommendations from the NCCN and other professional societies advocate universal screening for LS among young patients with CRC. However, practical implementation of these guidelines often falls short. Methods: We conducted a prospective quality improvement intervention trial to optimize universal screening for LS in young (age<50 years) patients, involving 356 eligible patients during the 12-month preintervention period and 299 patients during the postintervention. Results: Applying the Six Sigma conceptual framework, we demonstrated a significant increase in use of tumor-based molecular testing and subsequent confirmatory germline mutation testing for LS. This led to identification of more patients to be managed as having LS and of more first- and second-degree relatives to benefit from the testing results. Conclusions: This study demonstrated the successful application of a quality improvement conceptual framework for the universal adoption of molecular biomarker testing in patients with cancer, and for improving adherence to NCCN Clinical Practice Guidelines in Oncology for CRC Screening. As molecular and genetic testing is becoming increasingly common, we present a prototype study for improving the adoption of molecular studies and the provision of guideline-based patient-centered care. (J Natl Compr Canc Netw 2015;13:865-872).",
author = "Sean Dineen and Lynch, {Patrick M.} and Rodriguez-Bigas, {Miguel A.} and Sarah Bannon and Melissa Taggart and Colleen Reeves and Cathy Modaro and Michael Overman and Chang, {George J.} and Skibber, {John M.} and {Nancy You}, Y.",
year = "2015",
month = "7",
day = "1",
language = "English (US)",
volume = "13",
pages = "865--872",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer

AU - Dineen, Sean

AU - Lynch, Patrick M.

AU - Rodriguez-Bigas, Miguel A.

AU - Bannon, Sarah

AU - Taggart, Melissa

AU - Reeves, Colleen

AU - Modaro, Cathy

AU - Overman, Michael

AU - Chang, George J.

AU - Skibber, John M.

AU - Nancy You, Y.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background: Improving the quality of health care is a national priority, and providing patient-centered care is one of the 6 key areas for quality improvement. In the setting of patients with young-onset colorectal cancer (CRC), appropriate genetic workup and testing for potential underlying inherited CRC syndromes is fundamental to patient-centered care. Lynch syndrome (LS) is the most common of these inherited syndromes, and current recommendations from the NCCN and other professional societies advocate universal screening for LS among young patients with CRC. However, practical implementation of these guidelines often falls short. Methods: We conducted a prospective quality improvement intervention trial to optimize universal screening for LS in young (age<50 years) patients, involving 356 eligible patients during the 12-month preintervention period and 299 patients during the postintervention. Results: Applying the Six Sigma conceptual framework, we demonstrated a significant increase in use of tumor-based molecular testing and subsequent confirmatory germline mutation testing for LS. This led to identification of more patients to be managed as having LS and of more first- and second-degree relatives to benefit from the testing results. Conclusions: This study demonstrated the successful application of a quality improvement conceptual framework for the universal adoption of molecular biomarker testing in patients with cancer, and for improving adherence to NCCN Clinical Practice Guidelines in Oncology for CRC Screening. As molecular and genetic testing is becoming increasingly common, we present a prototype study for improving the adoption of molecular studies and the provision of guideline-based patient-centered care. (J Natl Compr Canc Netw 2015;13:865-872).

AB - Background: Improving the quality of health care is a national priority, and providing patient-centered care is one of the 6 key areas for quality improvement. In the setting of patients with young-onset colorectal cancer (CRC), appropriate genetic workup and testing for potential underlying inherited CRC syndromes is fundamental to patient-centered care. Lynch syndrome (LS) is the most common of these inherited syndromes, and current recommendations from the NCCN and other professional societies advocate universal screening for LS among young patients with CRC. However, practical implementation of these guidelines often falls short. Methods: We conducted a prospective quality improvement intervention trial to optimize universal screening for LS in young (age<50 years) patients, involving 356 eligible patients during the 12-month preintervention period and 299 patients during the postintervention. Results: Applying the Six Sigma conceptual framework, we demonstrated a significant increase in use of tumor-based molecular testing and subsequent confirmatory germline mutation testing for LS. This led to identification of more patients to be managed as having LS and of more first- and second-degree relatives to benefit from the testing results. Conclusions: This study demonstrated the successful application of a quality improvement conceptual framework for the universal adoption of molecular biomarker testing in patients with cancer, and for improving adherence to NCCN Clinical Practice Guidelines in Oncology for CRC Screening. As molecular and genetic testing is becoming increasingly common, we present a prototype study for improving the adoption of molecular studies and the provision of guideline-based patient-centered care. (J Natl Compr Canc Netw 2015;13:865-872).

UR - http://www.scopus.com/inward/record.url?scp=84938152790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938152790&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 865

EP - 872

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 7

ER -